Post-ischemic treatment with Toki-shakuyaku-san (Tang-Gui-Shao-Yao-San) prevents the impairment of spatial memory induced by repeated cerebral ischemia in rats

Fengling Pu, Kenichi Mishima, Nobuaki Egashira, Yuki Akiyoshi, An xin Liu, Kazunori Sano, Keiichi Irie, Daisuke Ishibashi, Izzettin Hatip-Al-Khatib, Kiyo Iwasaki, Kouji Kurauchi, Katsunori Iwasaki, Michihiro Fujiwara

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Previously we have reported that Toki-shakuyaku-san (TSS) ameliorated the impairment of spatial memory induced by single cerebral ischemia (1 × 10 minutes) and scopolamine, a muscarinic receptor antagonist. In this experiment, we studied the effect of TSS on repeated cerebral ischemia (2 × 10 minutes, 1-hour interval) induced impairment of spatial memory and neuronal injury in rats. The 8-day post-ischemic treatment with TSS (30-300 mg/kg) was administered p.o. once per day. TSS dose-dependently prevented the impairment of spatial memory, neuronal death and TUNEL positive cells induced by repeated cerebral ischemia. In order to determine the mechanism of TSS, we also studied the effect of TSS on GluR2 mRNA, one of the glutamate α-amino-3- hydroxy-5-methyl-4-isoxazole (AMPA) receptor subunits. Repeated cerebral ischemia significantly decreased GluR2 flop mRNA at 1 and 3 days after the occlusion. TSS (300 mg/kg) significantly suppressed the decrease in GluR2 flop at 3 days after repeated cerebral ischemia. These results suggested that the TSS has neuroprotective action which may be indirectly mediated by the AMPA receptor, and TSS may be beneficial for the treatment of cerebrovascular dementia.

Original languageEnglish
Pages (from-to)475-489
Number of pages15
JournalAmerican Journal of Chinese Medicine
Volume33
Issue number3
DOIs
Publication statusPublished - Jul 13 2005
Externally publishedYes

Fingerprint

Brain Ischemia
AMPA Receptors
Isoxazoles
toki-shakuyaku-san
Spatial Memory
Messenger RNA
Muscarinic Antagonists
Scopolamine Hydrobromide
In Situ Nick-End Labeling
Muscarinic Receptors
Dementia
Glutamic Acid
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Complementary and alternative medicine

Cite this

Post-ischemic treatment with Toki-shakuyaku-san (Tang-Gui-Shao-Yao-San) prevents the impairment of spatial memory induced by repeated cerebral ischemia in rats. / Pu, Fengling; Mishima, Kenichi; Egashira, Nobuaki; Akiyoshi, Yuki; Liu, An xin; Sano, Kazunori; Irie, Keiichi; Ishibashi, Daisuke; Hatip-Al-Khatib, Izzettin; Iwasaki, Kiyo; Kurauchi, Kouji; Iwasaki, Katsunori; Fujiwara, Michihiro.

In: American Journal of Chinese Medicine, Vol. 33, No. 3, 13.07.2005, p. 475-489.

Research output: Contribution to journalArticle

Pu, F, Mishima, K, Egashira, N, Akiyoshi, Y, Liu, AX, Sano, K, Irie, K, Ishibashi, D, Hatip-Al-Khatib, I, Iwasaki, K, Kurauchi, K, Iwasaki, K & Fujiwara, M 2005, 'Post-ischemic treatment with Toki-shakuyaku-san (Tang-Gui-Shao-Yao-San) prevents the impairment of spatial memory induced by repeated cerebral ischemia in rats', American Journal of Chinese Medicine, vol. 33, no. 3, pp. 475-489. https://doi.org/10.1142/S0192415X05003077
Pu, Fengling ; Mishima, Kenichi ; Egashira, Nobuaki ; Akiyoshi, Yuki ; Liu, An xin ; Sano, Kazunori ; Irie, Keiichi ; Ishibashi, Daisuke ; Hatip-Al-Khatib, Izzettin ; Iwasaki, Kiyo ; Kurauchi, Kouji ; Iwasaki, Katsunori ; Fujiwara, Michihiro. / Post-ischemic treatment with Toki-shakuyaku-san (Tang-Gui-Shao-Yao-San) prevents the impairment of spatial memory induced by repeated cerebral ischemia in rats. In: American Journal of Chinese Medicine. 2005 ; Vol. 33, No. 3. pp. 475-489.
@article{6616e2c9d1d4483993a9420a6c57867d,
title = "Post-ischemic treatment with Toki-shakuyaku-san (Tang-Gui-Shao-Yao-San) prevents the impairment of spatial memory induced by repeated cerebral ischemia in rats",
abstract = "Previously we have reported that Toki-shakuyaku-san (TSS) ameliorated the impairment of spatial memory induced by single cerebral ischemia (1 × 10 minutes) and scopolamine, a muscarinic receptor antagonist. In this experiment, we studied the effect of TSS on repeated cerebral ischemia (2 × 10 minutes, 1-hour interval) induced impairment of spatial memory and neuronal injury in rats. The 8-day post-ischemic treatment with TSS (30-300 mg/kg) was administered p.o. once per day. TSS dose-dependently prevented the impairment of spatial memory, neuronal death and TUNEL positive cells induced by repeated cerebral ischemia. In order to determine the mechanism of TSS, we also studied the effect of TSS on GluR2 mRNA, one of the glutamate α-amino-3- hydroxy-5-methyl-4-isoxazole (AMPA) receptor subunits. Repeated cerebral ischemia significantly decreased GluR2 flop mRNA at 1 and 3 days after the occlusion. TSS (300 mg/kg) significantly suppressed the decrease in GluR2 flop at 3 days after repeated cerebral ischemia. These results suggested that the TSS has neuroprotective action which may be indirectly mediated by the AMPA receptor, and TSS may be beneficial for the treatment of cerebrovascular dementia.",
author = "Fengling Pu and Kenichi Mishima and Nobuaki Egashira and Yuki Akiyoshi and Liu, {An xin} and Kazunori Sano and Keiichi Irie and Daisuke Ishibashi and Izzettin Hatip-Al-Khatib and Kiyo Iwasaki and Kouji Kurauchi and Katsunori Iwasaki and Michihiro Fujiwara",
year = "2005",
month = "7",
day = "13",
doi = "10.1142/S0192415X05003077",
language = "English",
volume = "33",
pages = "475--489",
journal = "American Journal of Chinese Medicine",
issn = "0192-415X",
publisher = "World Scientific Publishing Co. Pte Ltd",
number = "3",

}

TY - JOUR

T1 - Post-ischemic treatment with Toki-shakuyaku-san (Tang-Gui-Shao-Yao-San) prevents the impairment of spatial memory induced by repeated cerebral ischemia in rats

AU - Pu, Fengling

AU - Mishima, Kenichi

AU - Egashira, Nobuaki

AU - Akiyoshi, Yuki

AU - Liu, An xin

AU - Sano, Kazunori

AU - Irie, Keiichi

AU - Ishibashi, Daisuke

AU - Hatip-Al-Khatib, Izzettin

AU - Iwasaki, Kiyo

AU - Kurauchi, Kouji

AU - Iwasaki, Katsunori

AU - Fujiwara, Michihiro

PY - 2005/7/13

Y1 - 2005/7/13

N2 - Previously we have reported that Toki-shakuyaku-san (TSS) ameliorated the impairment of spatial memory induced by single cerebral ischemia (1 × 10 minutes) and scopolamine, a muscarinic receptor antagonist. In this experiment, we studied the effect of TSS on repeated cerebral ischemia (2 × 10 minutes, 1-hour interval) induced impairment of spatial memory and neuronal injury in rats. The 8-day post-ischemic treatment with TSS (30-300 mg/kg) was administered p.o. once per day. TSS dose-dependently prevented the impairment of spatial memory, neuronal death and TUNEL positive cells induced by repeated cerebral ischemia. In order to determine the mechanism of TSS, we also studied the effect of TSS on GluR2 mRNA, one of the glutamate α-amino-3- hydroxy-5-methyl-4-isoxazole (AMPA) receptor subunits. Repeated cerebral ischemia significantly decreased GluR2 flop mRNA at 1 and 3 days after the occlusion. TSS (300 mg/kg) significantly suppressed the decrease in GluR2 flop at 3 days after repeated cerebral ischemia. These results suggested that the TSS has neuroprotective action which may be indirectly mediated by the AMPA receptor, and TSS may be beneficial for the treatment of cerebrovascular dementia.

AB - Previously we have reported that Toki-shakuyaku-san (TSS) ameliorated the impairment of spatial memory induced by single cerebral ischemia (1 × 10 minutes) and scopolamine, a muscarinic receptor antagonist. In this experiment, we studied the effect of TSS on repeated cerebral ischemia (2 × 10 minutes, 1-hour interval) induced impairment of spatial memory and neuronal injury in rats. The 8-day post-ischemic treatment with TSS (30-300 mg/kg) was administered p.o. once per day. TSS dose-dependently prevented the impairment of spatial memory, neuronal death and TUNEL positive cells induced by repeated cerebral ischemia. In order to determine the mechanism of TSS, we also studied the effect of TSS on GluR2 mRNA, one of the glutamate α-amino-3- hydroxy-5-methyl-4-isoxazole (AMPA) receptor subunits. Repeated cerebral ischemia significantly decreased GluR2 flop mRNA at 1 and 3 days after the occlusion. TSS (300 mg/kg) significantly suppressed the decrease in GluR2 flop at 3 days after repeated cerebral ischemia. These results suggested that the TSS has neuroprotective action which may be indirectly mediated by the AMPA receptor, and TSS may be beneficial for the treatment of cerebrovascular dementia.

UR - http://www.scopus.com/inward/record.url?scp=21344450766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21344450766&partnerID=8YFLogxK

U2 - 10.1142/S0192415X05003077

DO - 10.1142/S0192415X05003077

M3 - Article

C2 - 16047564

AN - SCOPUS:21344450766

VL - 33

SP - 475

EP - 489

JO - American Journal of Chinese Medicine

JF - American Journal of Chinese Medicine

SN - 0192-415X

IS - 3

ER -